Home > Covid 19 Rapid Test Kit >

FDA TGA Nasopharyngeal Antigen Test Flowflex Nasal Specimen

Product Categories

Disposable Protective Coverall [19]
Disposable Surgical Gown [16]
Disposable Medical Coverall [18]
Covid 19 Rapid Test Kit [19]
Disposable Nitrile Gloves [16]
Sars Cov 2 Rapid Test Kit [10]
Rapid Antigen Test Kit [6]
Medical Nitrile Gloves [11]
Powder Free Nitrile Gloves [10]
Disposable Isolation Gown [18]
Sterile Surgical Gown [15]
Sterile Nitrile Gloves [13]
Disposable Medical Latex Gloves [12]
Powder Free Latex Gloves [12]
Powdered Latex Gloves [18]
Vinyl Nitrile Blend Gloves [15]
Disposable Vinyl Gloves [18]
Disposable Protective Face Mask [12]

Shenzhen Signo Group Technology Co., Ltd.

Trust Seal

Verified Supplier

Credit Check

Supplier Assessment

Contact Now

FDA TGA Nasopharyngeal Antigen Test Flowflex Nasal Specimen

MOQ : 1000

Price : Negotiable

Payment Terms : L/C, D/P, T/T

Test Method : Nasal Specimen

Features : Store between 36° to 86° F/ 2.2° to 30°C

MOQ : 1000 Test

Packing : 1Test/Box

Materials Provided : Test Cassette(s)

Quantity : 1 Test

Contact Now

FDA TGA Nasopharyngeal Antigen Test Flowflex Nasal Specimen

A rapid test for the detection of SARS-CoV-2 antigens in anterior nasal specimens directly from individuals within 7 days of symptom onset or without symptoms or other epidemiological reasons to suspect COVID-19 infection.

Materials Provided:

•Test Cassette(s)

•Package Insert

•Extraction Buffer Tube(s)

•Nasal Swab(s)

• This product has not been FDA cleared or approved but has been authorized by FDA under an EUA.

• This product has been authorized only for the detection, not for any other viruses or pathogens.

• The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of IVDs

for detection and/or diagnosis of Clear 19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is

terminated, or authorization is revoked sooner.

• For more information on EUAs please visit: https://www.fda.gov/emergency-preparednessand-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization

• For the most up to date information on Clear 19, please visit: www.cdc.gov/Clear 19

• For detailed instructions, please visit: www.aconlabs.com

FDA TGA Nasopharyngeal Antigen Test Flowflex Nasal Specimen

Product Tags: